Advertisement
Screener

CONMED CORPORATION (CNMD) Increase (Decrease) in Operating Capital

2.8 / 5 stars · 68/120 Roast Me

CONMED CORPORATION Increase (Decrease) in Operating Capital

CONMED CORPORATION (CNMD) reported Increase (Decrease) in Operating Capital of -$66.51 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2020-02-24

  • CONMED CORPORATION increase (decrease) in operating capital for the quarter ending 2019-12-31 was -$25.94M.
  • CONMED CORPORATION increase (decrease) in operating capital for the quarter ending 2019-09-30 was -$29.63M, a 2110.18% decline year-over-year.
  • CONMED CORPORATION increase (decrease) in operating capital for the quarter ending 2019-06-30 was -$15.88M.
  • CONMED CORPORATION increase (decrease) in operating capital for the quarter ending 2019-03-31 was $4.94M.
  • CONMED CORPORATION increase (decrease) in operating capital for fiscal 2019 was -$66.51M.
  • CONMED CORPORATION increase (decrease) in operating capital for fiscal 2018 was -$33.85M.
  • CONMED CORPORATION increase (decrease) in operating capital for fiscal 2017 was -$10.08M.
  • CONMED CORPORATION increase (decrease) in operating capital for fiscal 2016 was -$25.22M.
Period endIncrease (Decrease) in Operating Capital 3 monthIncrease (Decrease) in Operating Capital 3 month as first filedIncrease (Decrease) in Operating Capital 6 monthIncrease (Decrease) in Operating Capital 6 month as first filedIncrease (Decrease) in Operating Capital 9 monthIncrease (Decrease) in Operating Capital 9 month as first filedIncrease (Decrease) in Operating Capital 12 monthIncrease (Decrease) in Operating Capital 12 month as first filed
2019-12-31-$25.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$55.57M
derived: sum of 2 quarters · filed 2020-02-24
-$71.45M
derived: sum of 3 quarters · filed 2020-02-24
-$66.51M
10-K · filed 2020-02-24
2019-09-30-$29.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
-$45.51M
derived: sum of 2 quarters · filed 2019-10-31
-$40.57M
10-Q · filed 2019-10-31
-$49.62M
derived: sum of 4 quarters · filed 2020-02-24
2019-06-30-$15.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$10.94M
10-Q · filed 2019-08-01
-$19.99M
derived: sum of 3 quarters · filed 2020-02-24
-$18.52M
derived: sum of 4 quarters · filed 2020-02-24
2019-03-31$4.94M
10-Q · filed 2019-04-26
-$4.11M
derived: sum of 2 quarters · filed 2020-02-24
-$2.63M
derived: sum of 3 quarters · filed 2020-02-24
-$14.54M
derived: sum of 4 quarters · filed 2020-02-24
2018-12-31-$9.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$7.58M
derived: sum of 2 quarters · filed 2020-02-24
-$19.48M
derived: sum of 3 quarters · filed 2020-02-24
-$33.85M
10-K · filed 2020-02-24
2018-09-30$1.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
-$10.43M
derived: sum of 2 quarters · filed 2019-10-31
-$24.80M
10-Q · filed 2019-10-31
$1.09M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30-$11.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$26.27M
10-Q · filed 2019-08-01
-$387.00K
derived: sum of 3 quarters · filed 2020-02-24
-$6.62M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31-$14.37M
10-Q · filed 2019-04-26
$11.52M
derived: sum of 2 quarters · filed 2020-02-24
$5.29M
derived: sum of 3 quarters · filed 2020-02-24
-$4.60M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$25.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$19.65M
derived: sum of 2 quarters · filed 2020-02-24
$9.76M
derived: sum of 3 quarters · filed 2020-02-24
-$10.08M
10-K · filed 2020-02-24
2017-09-30-$6.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
-$16.12M
derived: sum of 2 quarters · filed 2018-11-02
-$35.96M
10-Q · filed 2018-11-02
-$42.95M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30-$9.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$29.73M
10-Q · filed 2018-08-02
-$36.72M
derived: sum of 3 quarters · filed 2019-02-25
-$54.14M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$19.84M
10-Q · filed 2018-04-26
-$26.83M
derived: sum of 2 quarters · filed 2019-02-25
-$44.25M
derived: sum of 3 quarters · filed 2019-02-25
-$59.35M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31-$6.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
-$24.41M
derived: sum of 2 quarters · filed 2019-02-25
-$39.51M
derived: sum of 3 quarters · filed 2019-02-25
-$25.22M
10-K · filed 2019-02-25
-$23.56M
10-K · filed 2017-02-27
2016-09-30-$17.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$32.52M
derived: sum of 2 quarters · filed 2017-11-02
-$18.23M
10-Q · filed 2017-11-02
-$16.68M
10-Q · filed 2016-10-28
-$22.58M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$15.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
-$807.00K
10-Q · filed 2017-07-27
$742.00K
10-Q · filed 2016-07-28
-$5.15M
derived: sum of 3 quarters · filed 2018-02-26
-$9.94M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$14.29M
10-Q · filed 2017-04-27
$15.02M
10-Q · filed 2016-05-02
$9.95M
derived: sum of 2 quarters · filed 2018-02-26
$5.16M
derived: sum of 3 quarters · filed 2018-02-26
$2.37M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$9.14M
derived: sum of 2 quarters · filed 2018-02-26
-$11.92M
derived: sum of 3 quarters · filed 2018-02-26
-$20.42M
10-K · filed 2018-02-26
-$17.57M
10-K · filed 2016-02-23
2015-09-30-$4.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
-$7.58M
derived: sum of 2 quarters · filed 2016-10-28
-$16.07M
10-Q · filed 2016-10-28
-$30.38M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
-$11.28M
10-Q · filed 2016-07-28
-$25.59M
derived: sum of 3 quarters · filed 2017-02-27
-$38.23M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$8.50M
10-Q · filed 2016-05-02
-$22.80M
derived: sum of 2 quarters · filed 2017-02-27
-$35.45M
derived: sum of 3 quarters · filed 2017-02-27
-$33.08M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$14.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$26.95M
derived: sum of 2 quarters · filed 2017-02-27
-$24.59M
derived: sum of 3 quarters · filed 2017-02-27
-$32.98M
10-K · filed 2017-02-27
2014-09-30-$12.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23
-$10.28M
derived: sum of 2 quarters · filed 2015-10-23
-$18.68M
10-Q · filed 2015-10-23
-$35.76M
derived: sum of 4 quarters · filed 2016-02-23
2014-06-30$2.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-27
-$6.03M
10-Q · filed 2015-07-27
-$23.12M
derived: sum of 3 quarters · filed 2016-02-23
-$47.91M
derived: sum of 4 quarters · filed 2016-02-23
2014-03-31-$8.40M
10-Q · filed 2015-04-24
-$25.48M
derived: sum of 2 quarters · filed 2016-02-23
-$50.28M
derived: sum of 3 quarters · filed 2016-02-23
-$58.43M
derived: sum of 4 quarters · filed 2016-02-23
2013-12-31-$17.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
-$41.88M
derived: sum of 2 quarters · filed 2016-02-23
-$50.03M
derived: sum of 3 quarters · filed 2016-02-23
-$45.01M
10-K · filed 2016-02-23
2013-09-30-$24.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24
-$32.95M
derived: sum of 2 quarters · filed 2014-10-24
-$27.93M
10-Q · filed 2014-10-24
-$50.97M
derived: sum of 4 quarters · filed 2015-02-23
2013-06-30-$8.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25
-$3.13M
10-Q · filed 2014-07-25
-$26.17M
derived: sum of 3 quarters · filed 2015-02-23
-$44.83M
derived: sum of 4 quarters · filed 2015-02-23
2013-03-31$5.02M
10-Q · filed 2014-04-25
-$18.02M
derived: sum of 2 quarters · filed 2015-02-23
-$36.69M
derived: sum of 3 quarters · filed 2015-02-23
-$52.04M
derived: sum of 4 quarters · filed 2015-02-23
2012-12-31-$23.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23
-$41.70M
derived: sum of 2 quarters · filed 2015-02-23
-$57.06M
derived: sum of 3 quarters · filed 2015-02-23
-$54.72M
10-K · filed 2015-02-23
2012-09-30-$18.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
-$34.02M
derived: sum of 2 quarters · filed 2013-10-28
-$31.68M
10-Q · filed 2013-10-28
-$83.10M
derived: sum of 4 quarters · filed 2014-02-24
2012-06-30-$15.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
-$13.01M
10-Q · filed 2013-07-29
-$64.43M
derived: sum of 3 quarters · filed 2014-02-24
-$92.71M
derived: sum of 4 quarters · filed 2014-02-24
2012-03-31$2.34M
10-Q · filed 2013-04-29
-$49.08M
derived: sum of 2 quarters · filed 2014-02-24
-$77.35M
derived: sum of 3 quarters · filed 2014-02-24
-$88.20M
derived: sum of 4 quarters · filed 2014-02-24
2011-12-31-$51.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
-$79.69M
derived: sum of 2 quarters · filed 2014-02-24
-$90.54M
derived: sum of 3 quarters · filed 2014-02-24
-$102.24M
10-K · filed 2014-02-24
2011-09-30-$28.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
-$39.12M
derived: sum of 2 quarters · filed 2012-10-29
-$50.82M
10-Q · filed 2012-10-29
-$66.81M
derived: sum of 4 quarters · filed 2013-02-25
2011-06-30-$10.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
-$22.55M
10-Q · filed 2012-07-30
$22.55M
10-Q · filed 2011-08-09
-$38.54M
derived: sum of 3 quarters · filed 2013-02-25
-$21.34M
derived: sum of 4 quarters · filed 2013-02-25
2011-03-31-$11.71M
10-Q · filed 2012-05-01
-$27.70M
derived: sum of 2 quarters · filed 2013-02-25
-$10.50M
derived: sum of 3 quarters · filed 2013-02-25
2010-12-31-$15.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25
$1.21M
derived: sum of 2 quarters · filed 2013-02-25
-$7.90M
10-K · filed 2013-02-25
2010-09-30$17.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01
$8.09M
10-Q · filed 2011-11-01
2010-06-30-$9.10M
10-Q · filed 2011-08-09
2009-12-31-$12.89M
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ceribell, Inc. (CBLL)United States$0.916B-11.27
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
Axogen, Inc. (AXGN)United States$2.329B-73.83
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B